Francesco Peyronel

654 total citations
26 papers, 314 citations indexed

About

Francesco Peyronel is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Nephrology. According to data from OpenAlex, Francesco Peyronel has authored 26 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Rheumatology, 10 papers in Pulmonary and Respiratory Medicine and 7 papers in Nephrology. Recurrent topics in Francesco Peyronel's work include IgG4-Related and Inflammatory Diseases (7 papers), Systemic Lupus Erythematosus Research (5 papers) and Eosinophilic Disorders and Syndromes (4 papers). Francesco Peyronel is often cited by papers focused on IgG4-Related and Inflammatory Diseases (7 papers), Systemic Lupus Erythematosus Research (5 papers) and Eosinophilic Disorders and Syndromes (4 papers). Francesco Peyronel collaborates with scholars based in Italy, France and United States. Francesco Peyronel's co-authors include Augusto Vaglio, Federica Maritati, Giovanni Maria Rossi, Enrico Fiaccadori, Giuseppe Regolisti, Paride Fenaroli, Maria Letizia Urban, Umberto Maggiore, Mohamed G. Atta and N. Schleinitz and has published in prestigious journals such as Blood, Kidney International and Frontiers in Immunology.

In The Last Decade

Francesco Peyronel

23 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesco Peyronel Italy 10 195 97 82 63 58 26 314
Rakhi Seth United Kingdom 6 149 0.8× 90 0.9× 33 0.4× 123 2.0× 27 0.5× 7 309
C Fonnesu Italy 7 70 0.4× 59 0.6× 28 0.3× 41 0.7× 47 0.8× 13 270
César Jiménez Spain 8 162 0.8× 67 0.7× 32 0.4× 13 0.2× 29 0.5× 25 368
R. Goucha Tunisia 10 63 0.3× 90 0.9× 18 0.2× 123 2.0× 31 0.5× 62 346
Wattana Chartapisak Thailand 8 79 0.4× 27 0.3× 31 0.4× 82 1.3× 23 0.4× 18 225
W Chen China 6 94 0.5× 47 0.5× 50 0.6× 60 1.0× 12 0.2× 10 253
Yasuaki Kijima Japan 8 186 1.0× 112 1.2× 100 1.2× 69 1.1× 9 0.2× 12 301
Peter E. Callegari United States 7 127 0.7× 76 0.8× 26 0.3× 25 0.4× 37 0.6× 11 346
Bhadran Bose Australia 9 74 0.4× 110 1.1× 48 0.6× 287 4.6× 23 0.4× 27 412
Dimitrios-Anestis Moutzouris Greece 6 149 0.8× 41 0.4× 30 0.4× 197 3.1× 11 0.2× 7 357

Countries citing papers authored by Francesco Peyronel

Since Specialization
Citations

This map shows the geographic impact of Francesco Peyronel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Peyronel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Peyronel more than expected).

Fields of papers citing papers by Francesco Peyronel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Peyronel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Peyronel. The network helps show where Francesco Peyronel may publish in the future.

Co-authorship network of co-authors of Francesco Peyronel

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Peyronel. A scholar is included among the top collaborators of Francesco Peyronel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Peyronel. Francesco Peyronel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peyronel, Francesco, Alessandra Palmisano, Federica Maritati, et al.. (2025). Methotrexate and low-dose prednisone in idiopathic retroperitoneal fibrosis: a randomised clinical trial. Journal of Autoimmunity. 157. 103487–103487.
2.
Pegoraro, Francesco, Francesco Peyronel, Matthias Papo, et al.. (2025). Risk of Second Cancer in Erdheim-Chester Disease. JAMA Oncology. 11(4). 429–429. 2 indexed citations
3.
Allinovi, Marco, Cinzia Finocchi, Leonardo Caroti, et al.. (2025). Urinary rituximab loss and rate of treatment failure in membranous nephropathy. Nephrology Dialysis Transplantation. 41(1). 92–101. 2 indexed citations
4.
Peyronel, Francesco, Emanuel Della‐Torre, Federica Maritati, et al.. (2025). IgG4-related disease and other fibro-inflammatory conditions. Nature Reviews Rheumatology. 21(5). 275–290. 4 indexed citations
5.
6.
Volpi, Stefano, Maria Lucia Angelotti, Giulia Antonelli, et al.. (2024). Lupus Nephritis Patterns and Response to Type I Interferon in Patients With DNASE1L3 Variants: Report of Three Cases. American Journal of Kidney Diseases. 84(6). 791–797. 5 indexed citations
7.
Peyronel, Francesco, et al.. (2024). Early-onset lupus nephritis. Clinical Kidney Journal. 17(8). sfae212–sfae212. 5 indexed citations
8.
Peyronel, Francesco, Filippo Fagni, Andrea Minervini, et al.. (2023). Kidney involvement in Rosai-Dorfman disease. Kidney International. 103(1). 231–232. 4 indexed citations
9.
Gianfreda, Davide, et al.. (2023). Chronic periaortitis: A clinical approach. La Revue de Médecine Interne. 44(2). 79–84. 4 indexed citations
10.
Rossi, Giovanni Maria, Umberto Maggiore, Francesco Peyronel, et al.. (2022). Persistent Isolated C3 Hypocomplementemia as a Strong Predictor of End-Stage Kidney Disease in Lupus Nephritis. Kidney International Reports. 7(12). 2647–2656. 8 indexed citations
11.
Peyronel, Francesco, Elisabetta Parenti, Paride Fenaroli, et al.. (2020). Integrated strategies to prevent intradialytic hypotension: research protocol of the DialHypot study, a prospective randomised clinical trial in hypotension-prone haemodialysis patients. BMJ Open. 10(7). e036893–e036893. 4 indexed citations
12.
Rossi, Giovanni Maria, Francesco Peyronel, Steven Menez, et al.. (2020). Low-Level Proteinuria in Systemic Lupus Erythematosus. Kidney International Reports. 5(12). 2333–2340. 32 indexed citations
13.
Pegoraro, Francesco, Francesco Peyronel, Pieter J. Westenend, et al.. (2020). Long-term follow-up of mTOR inhibition for Erdheim-Chester disease. Blood. 135(22). 1994–1997. 19 indexed citations
14.
Rossi, Giovanni Maria, Giuseppe Regolisti, Francesco Peyronel, & Enrico Fiaccadori. (2020). Recent insights into sodium and potassium handling by the aldosterone-sensitive distal nephron: implications on pathophysiology and drug discovery. Journal of Nephrology. 33(3). 447–466. 9 indexed citations
15.
Rossi, Giovanni Maria, Giuseppe Regolisti, Francesco Peyronel, & Enrico Fiaccadori. (2020). Recent insights into sodium and potassium handling by the aldosterone-sensitive distal nephron: a review of the relevant physiology. Journal of Nephrology. 33(3). 431–445. 23 indexed citations
16.
Mario, Francesca Di, et al.. (2020). A case of extreme hyperphosphatemia due to sodium phosphate enemas successfully treated with sustained low efficiency dialysis. Clinical Nephrology. 95(1). 62–64. 4 indexed citations
17.
Sabatino, Alice, Giuseppe Regolisti, Francesca Di Mario, et al.. (2019). Validation by CT scan of quadriceps muscle thickness measurement by ultrasound in acute kidney injury. Journal of Nephrology. 33(1). 109–117. 28 indexed citations
18.
Maritati, Federica, Rossana Rocco, Chiara Marvisi, et al.. (2019). Clinical and Prognostic Significance of Serum IgG4 in Chronic Periaortitis. An Analysis of 113 Patients. Frontiers in Immunology. 10. 693–693. 20 indexed citations
19.
Nicastro, Maria, Rosanna Vescovini, Federica Maritati, et al.. (2019). Fibrocytes in Chronic Periaortitis: A Novel Mechanism Linking Inflammation and Fibrosis. Arthritis & Rheumatology. 71(11). 1913–1922. 20 indexed citations
20.
Peyronel, Francesco, Paride Fenaroli, Alessandro Palumbo, et al.. (2018). A misleading diagnosis of granulomatosis with polyangiitis disguising Whipple’s disease. Lara D. Veeken. 57(7). 1307–1309.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rakhi Seth Breakdown of academic impact, for papers by C Fonnesu Breakdown of academic impact, for papers by César Jiménez Breakdown of academic impact, for papers by R. Goucha Breakdown of academic impact, for papers by Wattana Chartapisak Breakdown of academic impact, for papers by W Chen Breakdown of academic impact, for papers by Yasuaki Kijima Breakdown of academic impact, for papers by Peter E. Callegari Breakdown of academic impact, for papers by Bhadran Bose Breakdown of academic impact, for papers by Dimitrios-Anestis Moutzouris
Rankless by CCL
2026